Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
出版年份 2018 全文链接
标题
Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
作者
关键词
-
出版物
Frontiers in Oncology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-05-24
DOI
10.3389/fonc.2018.00173
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mathematical Models for Cell Migration with Real-Time Cell Cycle Dynamics
- (2018) Sean T. Vittadello et al. BIOPHYSICAL JOURNAL
- Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
- (2018) Julia Boshuizen et al. NATURE MEDICINE
- Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities
- (2017) Nikolas K. Haass et al. EXPERIMENTAL DERMATOLOGY
- Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
- (2017) Paola Falletta et al. GENES & DEVELOPMENT
- Epigenetics in cancer stem cells
- (2017) Tan Boon Toh et al. Molecular Cancer
- The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma
- (2017) Antonio Ahn et al. MOLECULAR CANCER THERAPEUTICS
- A slow-cycling subpopulation of melanoma cells with highly invasive properties
- (2017) M Perego et al. ONCOGENE
- Intratumor and Intertumor Heterogeneity in Melanoma
- (2017) Tomasz M. Grzywa et al. Translational Oncology
- Microenvironment-derived factors driving metastatic plasticity in melanoma
- (2017) Isabella S. Kim et al. Nature Communications
- Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-Alpha
- (2017) Arne Kienzle et al. Advanced Healthcare Materials
- NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF
- (2017) Mitchell E. Fane et al. EBioMedicine
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Immune Checkpoint Therapy in Melanoma
- (2016) Margaret K. Callahan CANCER JOURNAL
- Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
- (2016) Matteo S. Carlino et al. CLINICAL CANCER RESEARCH
- Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
- (2016) Sarah J. Welsh et al. EUROPEAN JOURNAL OF CANCER
- Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells
- (2016) Kimberley A. Beaumont et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma
- (2016) Y. Qin et al. MOLECULAR CANCER THERAPEUTICS
- sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
- (2016) Amanpreet Kaur et al. NATURE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Targeting MITF in the tolerance-phase
- (2016) Imanol Arozarena et al. Oncotarget
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- Tumors and Mitochondrial Respiration: A Neglected Connection
- (2015) Andrea Viale et al. CANCER RESEARCH
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Complete remission of metastatic melanoma upon BRAF inhibitor treatment – what happens after discontinuation?
- (2015) Henrike Tolk et al. MELANOMA RESEARCH
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy
- (2015) Claudia Wellbrock et al. Pigment Cell & Melanoma Research
- Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids
- (2015) Kimberley A. Beaumont et al. Jove-Journal of Visualized Experiments
- Mitochondrial oxidative stress is the achille’s heel of melanoma cells resistant to Braf-mutant inhibitor
- (2015) Paola Corazao-Rozas et al. Oncotarget
- MITF in melanoma: mechanisms behind its expression and activity
- (2014) Mariusz L. Hartman et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
- (2014) H. Rizos et al. CLINICAL CANCER RESEARCH
- Melanoma never says die
- (2014) Nikolas K. Haass et al. EXPERIMENTAL DERMATOLOGY
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- A stress-induced early innate response causes multidrug tolerance in melanoma
- (2014) D Ravindran Menon et al. ONCOGENE
- Single-cell gene expression signatures reveal melanoma cell heterogeneity
- (2014) M Ennen et al. ONCOGENE
- Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
- (2014) A Roesch ONCOGENE
- Real-time cell cycle imaging during melanoma growth, invasion, and drug response
- (2014) Nikolas K. Haass et al. Pigment Cell & Melanoma Research
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNF
- (2014) M. P. Smith et al. Cancer Discovery
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
- (2014) Anna Chapman et al. Cell Reports
- Cancer heterogeneity: implications for targeted therapeutics
- (2013) R Fisher et al. BRITISH JOURNAL OF CANCER
- PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
- (2013) Francisca Vazquez et al. CANCER CELL
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- Molecular and cellular pathogenesis of melanoma initiation and progression
- (2013) Tarik Regad CELLULAR AND MOLECULAR LIFE SCIENCES
- Vemurafenib Induces Senescence Features in Melanoma Cells
- (2013) Sebastian Haferkamp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resistance to RAF Inhibitors Revisited
- (2013) Edward Hartsough et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Human skin neural crest progenitor cells are susceptible to BRAF V600E -induced transformation
- (2013) S M Kumar et al. ONCOGENE
- Melanoma’s connections to the tumour microenvironment
- (2013) Johanna M. Brandner et al. PATHOLOGY
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
- (2013) M. P. O'Connell et al. Cancer Discovery
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma
- (2012) Michael P. Smith et al. JNCI-Journal of the National Cancer Institute
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Systematic classification of melanoma cells by phenotype-specific gene expression mapping
- (2012) Daniel S. Widmer et al. Pigment Cell & Melanoma Research
- Snail1 Mediates Hypoxia-Induced Melanoma Progression
- (2011) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
- (2011) Omid Hamid et al. Journal of Translational Medicine
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- A picture of Mitf in melanoma immortality
- (2011) C R Goding ONCOGENE
- Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
- (2011) Y Cheli et al. ONCOGENE
- Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF
- (2011) E. Feige et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Slow-Cycling Therapy-Resistant Cancer Cells
- (2011) Nathan Moore et al. STEM CELLS AND DEVELOPMENT
- Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
- (2010) Sandy Giuliano et al. CANCER RESEARCH
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression
- (2010) Shujie He et al. MELANOMA RESEARCH
- Moving Targets That Drive Cancer Progression
- (2010) Mark Shackleton NEW ENGLAND JOURNAL OF MEDICINE
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance
- (2010) Nathan Moore et al. Journal of Oncology
- Tumor heterogeneity: Causes and consequences
- (2009) Andriy Marusyk et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Fifteen-year quest for microphthalmia-associated transcription factor target genes
- (2009) Yann Cheli et al. Pigment Cell & Melanoma Research
- Melanocytes: From Morphology to Application
- (2009) A. Santiago-Walker et al. SKIN PHARMACOLOGY AND PHYSIOLOGY
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation
- (2008) S. K. Dissanayake et al. CANCER RESEARCH
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
- (2008) Asako Sakaue-Sawano et al. CELL
- Novel MITF targets identified using a two-step DNA microarray strategy
- (2008) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
- (2008) Claudia Wellbrock et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started